Smith & Nephew报告说,以新产品和成本控制为例,Q4 2024的利润增至657M美元,增加了55%。 Smith & Nephew reports a 55% profit increase to $657M for Q4 2024, citing new products and cost controls.

Smith & Nephew是一家专门从事更换臀部和膝盖的医学技术公司,它报告说,在2024年最后一个季度,利润增加了55%,达到6.57亿美元,收入增加了7.8%。 Smith & Nephew, a medical tech company specializing in hip and knee replacements, reported a 55% profit increase to $657 million in the last quarter of 2024, with revenues up 7.8%. 首席执行官 Deepak Nath 将扭亏为盈归功于生产力的提高和严格的支出。 CEO Deepak Nath credits productivity improvements and disciplined spending for the turnaround. 60%以上的收入增长来自最近推出的产品,该公司预计2025年收入将增长5%,利润率将提高。 Over 60% of revenue growth came from recent product launches, and the company expects a 5% revenue increase in 2025 with higher margins.